SURGICAL TREATMENT OF ENDOMETRIAL CANCER

  • Stelio Rakar Ginekološka klinika Klinični center Šlajmerjeva 3 1525 Ljubljana
  • Leon Meglič Ginekološka klinika Klinični center Šlajmerjeva 3 1525 Ljubljana
  • Branko Cvjetičanin Ginekološka klinika Klinični center Šlajmerjeva 3 1525 Ljubljana
  • Borut Kobal Ginekološka klinika Klinični center Šlajmerjeva 3 1525 Ljubljana
Keywords: endometrial cancer, prognostic factors, surgical treatment, survival

Abstract

Background. Nowadays, endometrial cancer is the most frequent gynecologic malignancy with a relatively good prognosis. The prognosis and the quality of life of these patients can be improved considering the prognostic factors and more rational treatment.

Methods. This retrograde analysis comprised 499 patients with endometrial cancer operated at the Department of Obstetrics and Gynecology and then irradiated at the Institute of Oncology in Ljubljana in the period 1995–1999.

Results. Most patients had stage I disease (81.4%), good prognostic histological type (endometroid and adenoacanthoma in 81.3%), well- and moderately differentiated tumors (86%) and early myometrial invasion (72.4%). In the observed period we performed radical hysterectomy »old« Wertheim (Piver II) in only 8.4% of cases, in all other cases simple vaginal or abdominal hysterectomy (in 46.9% with pelvic lymphadenectomy) was done. Adjuvant irradiation was administered to 70% of patients. The analysis of 3- and 5-year survival comprises only 466 patients. The overall 5-year survival was 85.8%, in stage I cases 88.1%. There were no significant differences in survival in stage I cases regarding the type of surgery. In stage I the most important adverse prognostic factors were poor differentiation, deep myometrial invasion and serous-papillary histologic type, whereas lymph node involvement was very rare (less than 1%).

Conclusions. For the choice of appropriate surgical treatment of patients with endometrial cancer it is necessary to consider the prognostic factors. In this analysis a more radical surgical procedure did not improve the survival significantly. The usefulness of limphadenectomy in stage I remains open.

Downloads

Download data is not yet available.

References

Cancer Incidence in Slovenia 2000. Report No 42, Ljubljana: Onkološki inštitut, 2003.

Novak F. Primer carcinoma corpus uteri z metastaziranjem, kakor je običajno pri carcinoma colli uteri. Zdrav Vest 1953; 27: 205–6.

Pecorelli S ed. FIGO Annual report on the results of treatment of gynecological cancer. J Epidemiol Biostat 2001; 6: 3–3.

Look K. Stage I-II endometrial adenocarcinoma evolution of therapeutic paradigms: the role of surgery and adjuvant radiation. Int J Gynecol Cancer 2002; 12: 237–49.

Levine DA, Hoskin WJ. Update in the management of endometrial cancer. Cancer J 2002; 8, Suppl: 1: 531–40.

Rakar S, Gergolet M, Kovačič J, Eržen M. The choice of surgical treatment in endometrial cancer. In: Proceedings of the Second Meeting Alps-Adriatic Society of Gynecology. Bled, 5–6 December. Ljubljana: Združenje ginekologov Slovenije, 1997: 11–3.

Podratz KC, Mariani A, Webb MJ. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol 1998; 70: 163–4.

Van Doorn HC, van der Zee AGJ, Peeters PHM, Kroekds MVA, van Eijkeren MA. Preoperative selections of patients with low stage endometrial cancer at high risk of pelvic lymph node metastases. Int J Gynecol Cancer 2002; 23: 305–10.

Spirtos NM, Schlaerth JB, Gross GM et al. Cost and quality of life analysis of surgery for early endometrial cancer: laparotomy vs laparoscopy. Am J Obstet Gynecol 1996; 174: 1795–800.

Holub Z, Jabor A, Bartos P, Eim J, Vrbanek S, Pipovarnikova R. Laparoscopic surgery for endometrial cancer: Long-term results of a multicentric study. Eur J Gynecol Oncol 2002; 23: 305–10.

Poulsen HK, Jacobsen M, Bertelsen K et al. Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I low risk cases. Int J Gynecol Cancer 1996; 6: 38–43.

Elliott D, Green D, Coates A et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer 1994; 4: 84–93.

How to Cite
1.
Rakar S, Meglič L, Cvjetičanin B, Kobal B. SURGICAL TREATMENT OF ENDOMETRIAL CANCER. TEST ZdravVestn [Internet]. 1 [cited 5Aug.2024];72. Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/1962
Issue
Vol 72 (2003): Supplement II
Section
Professional Article


The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.

The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory

The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.

The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.

The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.